Pacific Biosciences of California, Inc. (PACB) , popularly known as PacBio, delivered an adjusted third-quarter 2024 loss per share of 17 cents, narrower than the year-ago quarter’s loss of 27 cents. The adjusted loss per share beat the Zacks Consensus Estimate by 15%.The company’s GAAP loss per share was 22 cents in the quarter, narrower than the year-ago period’s loss of 26 cents.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.Revenues in DetailPacBio registered revenues of $40 mi ...